{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:28:47Z","timestamp":1786580927830,"version":"build-2736575974"},"reference-count":126,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Androgen excess in postmenopausal women presents a challenging clinical conundrum. A crucial component in management involves identification of the underlying etiology with a focus on detection of potentially malignant pathology or underlying genetic syndromes. A basic understanding of androgen physiology in women and the associated alterations during the menopausal transition is required to accurately risk stratify this cohort and streamline investigations. Over the course of this article, we will propose an approach to investigation and management of postmenopausal androgen excess that focuses on clinical, biochemical, and radiological cues. Additionally, we will suggest an algorithmic approach to clinical and biochemical diagnostics that is underpinned by identification of red flag features of the underlying pathology.<\/jats:p>","DOI":"10.1210\/clinem\/dgag221","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:45:13Z","timestamp":1780055113000},"page":"2664-2677","source":"Crossref","is-referenced-by-count":0,"title":["Approach to the patient: investigation of postmenopausal androgen excess"],"prefix":"10.1210","volume":"111","author":[{"given":"Lauren","family":"Madden-Doyle","sequence":"first","affiliation":[{"name":"Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland (RCSI) , Dublin 9 ,","place":["Republic of Ireland"]},{"name":"Department of Endocrinology, Beaumont Hospital , Dublin D09V2N0 ,","place":["Republic of Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bowers","sequence":"additional","affiliation":[{"name":"Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland (RCSI) , Dublin 9 ,","place":["Republic of Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sherlock","sequence":"additional","affiliation":[{"name":"Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland (RCSI) , Dublin 9 ,","place":["Republic of Ireland"]},{"name":"Department of Endocrinology, Beaumont Hospital , Dublin D09V2N0 ,","place":["Republic of Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-9105","authenticated-orcid":false,"given":"Michael W","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Androgens in Health and Disease Research Group, Academic Division of Endocrinology, Department of Medicine, Royal College of Surgeons in Ireland (RCSI) , Dublin 9 ,","place":["Republic of Ireland"]},{"name":"Department of Endocrinology, Beaumont Hospital , Dublin D09V2N0 ,","place":["Republic of Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"4","key":"2026081219573901000_dgag221-B1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cen.15265","article-title":"Society for endocrinology clinical practice guideline for the evaluation of androgen excess in women","volume":"103","author":"Elhassan","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026081219573901000_dgag221-B2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11-12","key":"2026081219573901000_dgag221-B3","first-page":"625","article-title":"Reference intervals for testosterone, androstenedione and SHBG levels in healthy females and males from birth until old age","volume":"51","author":"Elmlinger","year":"2005","journal-title":"Clin Lab"},{"key":"2026081219573901000_dgag221-B4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2017.05.002","article-title":"Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS\/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status","volume":"470","author":"Eisenhofer","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"2","key":"2026081219573901000_dgag221-B5","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0468","article-title":"Hyperandrogenism after menopause","volume":"172","author":"Markopoulos","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026081219573901000_dgag221-B6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.2011-2134","article-title":"Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry","volume":"97","author":"Haring","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081219573901000_dgag221-B7","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026081219573901000_dgag221-B8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"2026081219573901000_dgag221-B9","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s40618-023-02297-9","article-title":"Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience","volume":"47","author":"Luque-Ramirez","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2026081219573901000_dgag221-B10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1210\/clinem\/dgac673","article-title":"Approach to investigation of hyperandrogenism in a postmenopausal woman","volume":"108","author":"Hirschberg","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219573901000_dgag221-B11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.surg.2004.06.046","article-title":"Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases","volume":"136","author":"Moreno","year":"2004","journal-title":"Surgery"},{"issue":"1","key":"2026081219573901000_dgag221-B12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"key":"2026081219573901000_dgag221-B13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2016.05.003","article-title":"Androgen excess: investigations and management","volume":"37","author":"Lizneva","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"2026081219573901000_dgag221-B14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219573901000_dgag221-B15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1043-2760(02)00609-4","article-title":"Dissecting human adrenal androgen production","volume":"13","author":"Rainey","year":"2002","journal-title":"Trends Endocrinol Metab"},{"issue":"3-5","key":"2026081219573901000_dgag221-B16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jsbmb.2007.09.015","article-title":"Regulation of the adrenal androgen biosynthesis","volume":"108","author":"Rainey","year":"2008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026081219573901000_dgag221-B17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","article-title":"A new Dawn for androgens: novel lessons from 11-oxygenated C19 steroids","volume":"441","author":"Pretorius","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2026081219573901000_dgag221-B18","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1093\/ejendo\/lvad047","article-title":"The clinical and biochemical significance of 11-oxygenated androgens in human health and disease","volume":"188","author":"Storbeck","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219573901000_dgag221-B19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026081219573901000_dgag221-B20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219573901000_dgag221-B21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/clinem\/dgae714","article-title":"Impaired 11\u03b2-hydroxysteroid dehydrogenase type 2 activity in kidney disease disrupts 11-oxygenated androgen biosynthesis","volume":"110","author":"Tomkins","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026081219573901000_dgag221-B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159867","article-title":"11-Ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer: potent androgens which can no longer be ignored","volume":"11","author":"Pretorius","year":"2016","journal-title":"PLoS One"},{"key":"2026081219573901000_dgag221-B23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsbmb.2018.06.013","article-title":"11-Oxygenated androgen precursors are the preferred substrates for aldo-keto reductase 1C3 (AKR1C3): implications for castration resistant prostate cancer","volume":"183","author":"Barnard","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"2026081219573901000_dgag221-B24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr Rev"},{"issue":"1-3","key":"2026081219573901000_dgag221-B25","first-page":"7","article-title":"Regulation of gonadal androgen secretion","volume":"18","author":"Franchimont","year":"1983","journal-title":"Horm Res"},{"key":"2026081219573901000_dgag221-B26","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fphar.2018.00940","article-title":"Intracrine regulation of estrogen and other sex steroid levels in endometrium and non-gynecological tissues; pathology, physiology, and drug discovery","volume":"9","author":"Konings","year":"2018","journal-title":"Front Pharmacol"},{"issue":"2","key":"2026081219573901000_dgag221-B27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.1.05762","article-title":"Androgen generation in adipose tissue in women with simple obesity\u2013a site-specific role for 17\u03b2-hydroxysteroid dehydrogenase type 5","volume":"183","author":"Quinkler","year":"2004","journal-title":"J Endocrinol"},{"issue":"3","key":"2026081219573901000_dgag221-B28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/beog.2002.0287","article-title":"Ovarian ageing and the menopausal transition","volume":"16","author":"Zapantis","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1-6","key":"2026081219573901000_dgag221-B29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0960-0760(98)00145-9","article-title":"The endocrinology of the menopause","volume":"69","author":"Burger","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2026081219573901000_dgag221-B30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cen.14401","article-title":"Longitudinal changes over three years in sex steroid hormone levels in women aged 70 years and over","volume":"94","author":"Islam","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026081219573901000_dgag221-B31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.beem.2004.02.006","article-title":"Dehydroepiandrosterone and ageing","volume":"18","author":"Arlt","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"2026081219573901000_dgag221-B32","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1210\/jcem.87.8.8741","article-title":"The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity","volume":"87","author":"Lasley","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026081219573901000_dgag221-B33","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1210\/jc.2009-0386","article-title":"Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition","volume":"94","author":"Crawford","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081219573901000_dgag221-B34","first-page":"645","article-title":"Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study","volume":"85","author":"Laughlin","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026081219573901000_dgag221-B35","first-page":"2832","article-title":"A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition","volume":"85","author":"Burger","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026081219573901000_dgag221-B36","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219573901000_dgag221-B37","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/gme.0b013e31823fe274","article-title":"Menopausal transition stage-specific changes in circulating adrenal androgens","volume":"19","author":"McConnell","year":"2012","journal-title":"Menopause"},{"issue":"7","key":"2026081219573901000_dgag221-B38","first-page":"642","article-title":"The endocrine transition around menopause\u2013a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women","volume":"78","author":"Overlie","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2026081219573901000_dgag221-B39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsbmb.2016.12.007","article-title":"Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology","volume":"168","author":"Labrie","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"2026081219573901000_dgag221-B40","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-Oxygenated c19 steroids do not decline with age in women","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026081219573901000_dgag221-B41","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1210\/jc.2015-2546","article-title":"Endogenous androgens and sex hormone-binding globulin in women and risk of metabolic syndrome and type 2 diabetes","volume":"100","author":"Fenske","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026081219573901000_dgag221-B42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2337\/db16-0473","article-title":"Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis","volume":"66","author":"Muka","year":"2017","journal-title":"Diabetes"},{"issue":"11","key":"2026081219573901000_dgag221-B43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081219573901000_dgag221-B44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"9","key":"2026081219573901000_dgag221-B45","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1515\/cclm-2022-1179","article-title":"Evaluation of testosterone, estradiol and progesterone immunoassay calibrators by liquid chromatography mass spectrometry","volume":"61","author":"Handelsman","year":"2023","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2026081219573901000_dgag221-B46","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219573901000_dgag221-B47","article-title":"Clinical utility of GnRH analogues in female androgen excess: highlighting diagnostic and therapeutic applications","volume":"1","author":"Doyle","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"2","key":"2026081219573901000_dgag221-B48","first-page":"89","article-title":"Ovarian hyperthecosis presenting as polycythemia","volume":"11","author":"Jaiswal","year":"2025","journal-title":"AACE Clin Case Rep"},{"issue":"3","key":"2026081219573901000_dgag221-B49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med"},{"issue":"9","key":"2026081219573901000_dgag221-B50","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study","volume":"106","author":"Berni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081219573901000_dgag221-B51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","article-title":"Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria-a prospective population-based cohort study","volume":"189","author":"Ollila","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026081219573901000_dgag221-B52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cen.13862","article-title":"Serum testosterone, sex hormone-binding globulin and sex-specific risk of incident type 2 diabetes in a retrospective primary care cohort","volume":"90","author":"O\u2019Reilly","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026081219573901000_dgag221-B53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219573901000_dgag221-B54","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.fertnstert.2010.02.015","article-title":"Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes","volume":"94","author":"Wiltgen","year":"2010","journal-title":"Fertil Steril"},{"issue":"5","key":"2026081219573901000_dgag221-B55","doi-asserted-by":"crossref","DOI":"10.1530\/REP-24-0485","article-title":"POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: the impact of polycystic ovary syndrome on reproductive health: a narrative review","volume":"169","author":"Owens","year":"2025","journal-title":"Reproduction"},{"issue":"1","key":"2026081219573901000_dgag221-B56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13697137.2017.1392501","article-title":"Prediction of age at menopause in women with polycystic ovary syndrome","volume":"21","author":"Minooee","year":"2018","journal-title":"Climacteric"},{"issue":"3","key":"2026081219573901000_dgag221-B57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/aogs.13489","article-title":"Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls","volume":"98","author":"Forslund","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"2026081219573901000_dgag221-B58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmad015","article-title":"PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis","volume":"29","author":"Millan-de-Meer","year":"2023","journal-title":"Hum Reprod Update"},{"issue":"6","key":"2026081219573901000_dgag221-B59","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"5","key":"2026081219573901000_dgag221-B60","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1210\/clinem\/dgad590","article-title":"Hyperandrogenism and cardiometabolic risk in pre- and postmenopausal women-what is the evidence?","volume":"109","author":"Hirschberg","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026081219573901000_dgag221-B61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/09513590.2021.1903419","article-title":"Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism","volume":"37","author":"Meczekalski","year":"2021","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2026081219573901000_dgag221-B62","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/0002-9378(90)90786-7","article-title":"Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis","volume":"163","author":"Nagamani","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2026081219573901000_dgag221-B63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2265.1997.1050916.x","article-title":"Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women","volume":"46","author":"Barth","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2026081219573901000_dgag221-B64","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09513590701807100","article-title":"The investigation and management of severe hyperandrogenism pre- and postmenopause: non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin","volume":"24","author":"Vaikkakara","year":"2008","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"2026081219573901000_dgag221-B65","article-title":"Ovarian hyperthecosis presenting with postmenopausal virilization and new-onset type 2 diabetes","volume":"3","author":"Knott","year":"2025","journal-title":"JCEM Case Rep"},{"issue":"6","key":"2026081219573901000_dgag221-B66","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/ijgc-2020-001235","article-title":"Rare ovarian tumors: an update on diagnosis and treatment","volume":"30","author":"Debuquoy","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2026081219573901000_dgag221-B67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00404-020-05588-1","article-title":"Ovarian Sertoli-Leydig cell tumors: an analysis of 13 cases","volume":"302","author":"Guo","year":"2020","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"2026081219573901000_dgag221-B68","first-page":"259","article-title":"Clinical analysis of 14 cases with androgen-secreting ovarian sex cord-stromal tumors: diagnosis, treatment, and literature review","volume":"46","author":"Sang","year":"2025","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"2026081219573901000_dgag221-B69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/20533691241304541","article-title":"Diagnostic pitfalls in ovarian androgen-secreting tumors in postmenopausal women with rapidly progressed severe hyperandrogenism","volume":"31","author":"Garzia","year":"2025","journal-title":"Post Reprod Health"},{"issue":"1","key":"2026081219573901000_dgag221-B70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/EJE-17-0111","article-title":"Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies","volume":"177","author":"Yance","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026081219573901000_dgag221-B71","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000478-198508000-00001","article-title":"Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2026081219573901000_dgag221-B72","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13193-012-0201-z","article-title":"Recent advances in granulosa cell tumor ovary: a review","volume":"4","author":"Kottarathil","year":"2013","journal-title":"Indian J Surg Oncol"},{"issue":"5","key":"2026081219573901000_dgag221-B73","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1469-0705.2000.00123.x","article-title":"Virilizing tumors of the ovary: imaging features","volume":"15","author":"Outwater","year":"2000","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"7","key":"2026081219573901000_dgag221-B74","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/09513590.2022.2083104","article-title":"From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach","volume":"38","author":"Rojewska","year":"2022","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2026081219573901000_dgag221-B75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-21-0510","article-title":"S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study","volume":"186","author":"Elhassan","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026081219573901000_dgag221-B76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ejendo\/lvag046","article-title":"Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study","volume":"194","author":"Mangone","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026081219573901000_dgag221-B77","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219573901000_dgag221-B78","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1210\/clinem\/dgac046","article-title":"Temporal trends in outcomes in patients with adrenocortical carcinoma: a multidisciplinary referral-center experience","volume":"107","author":"Daher","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026081219573901000_dgag221-B79","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1210\/clinem\/dgag088","article-title":"Time trends in incidence, treatment, and survival of patients with adrenocortical carcinoma, a nationwide study","volume":"111","author":"Steenaard","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026081219573901000_dgag221-B80","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"issue":"12","key":"2026081219573901000_dgag221-B81","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1210\/jc.2013-2281","article-title":"Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma","volume":"98","author":"Kerkhofs","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026081219573901000_dgag221-B82","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081219573901000_dgag221-B83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endrev\/bnab016","article-title":"Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management","volume":"43","author":"Claahsen-van der Grinten","year":"2022","journal-title":"Endocr Rev"},{"issue":"3","key":"2026081219573901000_dgag221-B84","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-18-0712","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency","volume":"180","author":"Nordenstrom","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026081219573901000_dgag221-B85","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1067\/mob.2000.108020","article-title":"21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study","volume":"183","author":"Moran","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2026081219573901000_dgag221-B86","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4158\/EP151085.RA","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as adrenal incidentaloma: a systematic review and meta-analysis","volume":"22","author":"Falhammar","year":"2016","journal-title":"Endocr Pract"},{"issue":"5","key":"2026081219573901000_dgag221-B87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-22-0320","article-title":"11-Oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing's disease","volume":"187","author":"Nowotny","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219573901000_dgag221-B88","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026081219573901000_dgag221-B89","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/000456329703400302","article-title":"Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome\u2013recommendations for a protocol for biochemistry laboratories","volume":"34","author":"Wood","year":"1997","journal-title":"Ann Clin Biochem"},{"key":"2026081219573901000_dgag221-B90","article-title":"Sertoli leydig cell tumor of the ovary in a woman with cushing syndrome: a case report","volume":"49","author":"Ofli","year":"2023","journal-title":"Gynecol Oncol Rep"},{"issue":"4","key":"2026081219573901000_dgag221-B91","doi-asserted-by":"crossref","first-page":"G49","DOI":"10.1093\/ejendo\/lvaf206","article-title":"European Society of Endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause","volume":"193","author":"Lumsden","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219573901000_dgag221-B92","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13697137.2019.1637079","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"22","author":"Davis","year":"2019","journal-title":"Climacteric"},{"issue":"2","key":"2026081219573901000_dgag221-B93","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/en.2003-0940","article-title":"Valproate potentiates androgen biosynthesis in human ovarian theca cells","volume":"145","author":"Nelson-DeGrave","year":"2004","journal-title":"Endocrinology"},{"issue":"11","key":"2026081219573901000_dgag221-B94","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026081219573901000_dgag221-B95","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"issue":"2","key":"2026081219573901000_dgag221-B96","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2026081219573901000_dgag221-B97","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1210\/clinem\/dgad461","article-title":"Clinical features and outcome analysis of type B insulin resistance syndrome: a single-center study in China","volume":"109","author":"Zhao","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026081219573901000_dgag221-B98","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1210\/clinem\/dgad467","article-title":"Systematic review-type B insulin resistance with isolated hypoglycemia and suppressed insulin","volume":"109","author":"Brown","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026081219573901000_dgag221-B99","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1994.tb01820.x","article-title":"Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours","volume":"41","author":"Pascale","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026081219573901000_dgag221-B100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4103\/ijem.IJEM_553_19","article-title":"Dynamic testing for evaluation of adrenal and gonadal function in pediatric and adult endocrinology: an overview","volume":"23","author":"Goyal","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"2026081219573901000_dgag221-B101","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cen.15019","article-title":"An unusual phenocopy for postmenopausal ovarian hyperandrogenism: LH-driven testosterone secretion by adrenal adenoma expressing luteinising hormone-chorionic gonadotrophin receptor","volume":"100","author":"Ali","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026081219573901000_dgag221-B102","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.01.2011.3730","article-title":"Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman","volume":"2011","author":"Chantler","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"6","key":"2026081219573901000_dgag221-B103","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1210\/jcem.83.6.4850","article-title":"Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression","volume":"83","author":"Arlt","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026081219573901000_dgag221-B104","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026081219573901000_dgag221-B105","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1093\/humrep\/der291","article-title":"Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test","volume":"26","author":"Rosenfield","year":"2011","journal-title":"Hum Reprod"},{"key":"2026081219573901000_dgag221-B106","volume-title":"Endotext","author":"Angelousi","year":"2000"},{"issue":"1","key":"2026081219573901000_dgag221-B107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota","volume":"29","author":"Young","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"2026081219573901000_dgag221-B108","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.seminoncol.2010.10.016","article-title":"Androgen- and estrogen-secreting adrenal cancers","volume":"37","author":"Cavlan","year":"2010","journal-title":"Semin Oncol"},{"issue":"3","key":"2026081219573901000_dgag221-B109","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/gyno.2000.5783","article-title":"Ovarian volume related to age","volume":"77","author":"Pavlik","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2026081219573901000_dgag221-B110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-0542","article-title":"Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism","volume":"165","author":"Sarfati","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081219573901000_dgag221-B111","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/uog.6131","article-title":"Ovarian hyperthecosis on grayscale and color Doppler ultrasound","volume":"32","author":"Rousset","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"2026081219573901000_dgag221-B112","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-09-0576","article-title":"Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma","volume":"162","author":"Dennedy","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026081219573901000_dgag221-B113","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/09513590.2021.1897099","article-title":"Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis","volume":"37","author":"Tng","year":"2021","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"2026081219573901000_dgag221-B114","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa172","article-title":"Gonadotropin-releasing hormone analogue stimulation test versus venous sampling in postmenopausal hyperandrogenism","volume":"5","author":"Tng","year":"2021","journal-title":"J Endocr Soc"},{"key":"2026081219573901000_dgag221-B115","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/IJWH.S475149","article-title":"Association between female androgen levels, metabolic syndrome, and cardiovascular disease: an NHANES analysis (2013-2016)","volume":"16","author":"Luo","year":"2024","journal-title":"Int J Womens Health"},{"issue":"5","key":"2026081219573901000_dgag221-B116","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1210\/js.2018-00405","article-title":"Persistent poor metabolic profile in postmenopausal women with ovarian hyperandrogenism after testosterone level normalization","volume":"3","author":"Rocha","year":"2019","journal-title":"J Endocr Soc"},{"issue":"9","key":"2026081219573901000_dgag221-B117","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41416-021-01518-3","article-title":"Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses","volume":"125","author":"Mullee","year":"2021","journal-title":"Br J Cancer"},{"key":"2026081219573901000_dgag221-B118","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humpath.2016.09.021","article-title":"Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases","volume":"59","author":"Zhang","year":"2017","journal-title":"Hum Pathol"},{"issue":"16","key":"2026081219573901000_dgag221-B119","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/jnci\/djg022","article-title":"Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women","volume":"95","author":"Key","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2026081219573901000_dgag221-B120","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1530\/ERC-18-0429","article-title":"Androgen excess in breast cancer development: implications for prevention and treatment","volume":"26","author":"Secreto","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2026081219573901000_dgag221-B121","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41523-026-00924-1","article-title":"Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer","volume":"12","author":"Bleach","year":"2026","journal-title":"NPJ Breast Cancer"},{"key":"2026081219573901000_dgag221-B122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106445","article-title":"Urine steroid metabolomics as a diagnostic tool in primary aldosteronism","volume":"237","author":"Prete","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"2026081219573901000_dgag221-B123","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/er.2018-00262","article-title":"Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism","volume":"40","author":"Storbeck","year":"2019","journal-title":"Endocr Rev"},{"issue":"2","key":"2026081219573901000_dgag221-B124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-18-0782","article-title":"Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma","volume":"180","author":"Schweitzer","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2026081219573901000_dgag221-B125","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.metabol.2017.03.002","article-title":"Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome","volume":"71","author":"Chang","year":"2017","journal-title":"Metabolism"},{"issue":"2","key":"2026081219573901000_dgag221-B126","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/humrep\/deac254","article-title":"Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testing","volume":"38","author":"Bachelot","year":"2023","journal-title":"Hum Reprod"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag221\/68434694\/dgag221.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/2664\/68434694\/dgag221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/9\/2664\/68434694\/dgag221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:58:00Z","timestamp":1786579080000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/9\/2664\/8698360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":126,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5,30]]},"published-print":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag221","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,5,30]]}}}